Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine

Clinical trial NCT07416656 · RECRUITING

Trial details

NCT number: NCT07416656
Sponsor: Klavs Würgler Hansen
Status: RECRUITING
Study type: OBSERVATIONAL

Inflammatory Arthritis Diabetes (DM)Rheumatoid Arthritis (RA)Type 1 Diabetes Mellitus Type 2 Diabetes (T2DM)

Start date: 2026-03-10
Primary completion: 2026-09-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.